Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Smoldering Multiple Myeloma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Helsinki University Hospital, Helsinki, Finland

    Lievonen
  • CHD Vendée, La Roche-sur-Yon, France

    Tiab
  • CHRU de Lille - Hopital Claude Huriez, Lille, France

    Manier
  • CHU Saint Eloi Département d'Hématologie Clinique, Montpellier, France

    Vincent
  • CHU Hôtel-Dieu, 1, place Alexis Ricordeau, 44093 NANTES Cedex 1, FRANCE, Nantes, France

    Contact: Study coordinator (Cyrille TOUZEAU, MD)
  • CHU NICE - Hôpital Archet, Nice, France

    Contact: Study coordinator (Richez - Olivier)
  • CHU Poitiers - Pôle régional de Cancérologie, Poitiers, France

    Leleu
    Contact: Principal Investigator (Leleu)
  • CHRU Hôpital Bretonneau, Tours, France

    Chalopin
  • Alexandra General Hospital -Department of Clinical Therapeutics N.K. Univ. of Athens, Athens, Greece

    Contact: Study coordinator (Evangelos Terpos)
  • AOU Consorziale Policlinico di Bari, Bari, Italy

    Contact: Study coordinator (Pellegrino Musto, Prof.)
  • A.O. Papa Giovanni XXIII, Bergamo, Italy

    Rambaldi
  • A.O.U. Careggi, Florence, Italy

    Antonioli
  • A.O.U. Policlinico S. Martino - Ematologia, Genova, Italy

    Aquino
    Contact: Principal Investigator (Aquino)
  • Meldola-Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola, Italy

    Cerchione
  • Ospedale Papardo, Messina, Italy

    Mannina
  • A.O.U. Maggiore della Carità Novara, Novara, Italy

    Contact: Study coordinator (Margiotta Casaluci)
  • A.O. di Padova, Padova, Italy

    Zambello
  • A.O.U. di Parma - U.O Ematologia e CTMO, Parma, Italy

    Giuliani
  • Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy

    Mangiacavalli
  • Ospedale Santo Spirito Ospedale -Azienda Sanitaria Locale Di Pescara, Roma, Italy

    Liberatore
  • Clinica Ematologica Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy

    Patriarca
  • Maastricht UMC, Maastricht, Netherlands

    Contact: Study coordinator (van Elsen)
  • St. Antonius Ziekenhuis, Nieuwegein, Netherlands

    Nijhoff
  • Erasmus MC, Rotterdam, Netherlands

    Broijl
  • Oslo Myeloma Center, Oslo, Norway

    Contact: Study coordinator (Friedrik Schjesvold)